Paras Healthcare IPO: SEBI Nod for Rs 1,800 Cr Fundraise
Paras Healthcare IPO approval, Rs 1,800 crore target.
Key Highlights
Paras Healthcare secures SEBI approval for its Rs 1,800 crore IPO, comprising a fresh issue and OFS, to fund debt repayment and corporate needs.
Paras Healthcare secured key approval from the Securities and Board of India (SEBI) for its (IPO), targeting a raise of Rs 1,800 crore.
IPO Structure Breakdown
- Total IPO size: Rs 1,800 crore
- of equity shares: up to Rs 500 crore
- Offer-For-Sale () by selling shareholder: Rs 1,300 crore
The fresh issue component is specifically designated to address financial liabilities. Funds are earmarked for the prepayment or repayment of certain outstanding borrowings, alongside an investment into PMHPL, its wholly-owned subsidiary, for its debt obligations.
Additionally, a portion of the fresh issue proceeds will be allocated towards general corporate purposes. This strategic funding aims to bolster the company’s financial position and operational flexibility moving forward.
Market Listing and Management
The equity shares of Paras Healthcare are slated for listing on both the and , expanding its presence in India’s major stock exchanges. This move marks a significant milestone for the healthcare provider.
Guiding this public offering are prominent financial institutions. JM Financial, BofA Securities India, and Nuvama Wealth Management have been appointed as the book-running lead managers for the issue, overseeing the process.
Operational Snapshot
Paras Healthcare operates as a specialized clinical hospital platform. Its current network comprises eight hospitals, which collectively offer a total capacity of 2,211 beds as reported on March 31, 2026.
This substantial bed count underscores its significant operational footprint within the healthcare sector. The company focuses on delivering clinical specialty-led services across its facilities.